Morgan Stanley Maintains Equal-Weight on GE HealthCare Techs, Lowers Price Target to $74
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on GE HealthCare Techs (NASDAQ:GEHC) but reduced the price target from $78 to $74.
December 04, 2023 | 12:39 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley analyst has maintained the Equal-Weight rating on GE HealthCare Techs but lowered the price target from $78 to $74, indicating a potential downside compared to the previous target.
The reduction in price target by Morgan Stanley suggests that they see less upside potential for GE HealthCare Techs, which could lead to a negative short-term reaction in the stock price. However, the maintenance of an Equal-Weight rating indicates that the overall outlook on the company remains unchanged.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100